Ross J M, McIntire L V, Moake J L, Rand J H
Cox Laboratory for Biomedical Engineering, Rice University, Houston, TX77251, USA.
Blood. 1995 Apr 1;85(7):1826-35.
Type VI collagen is a subendothelial constituent that binds von Willebrand factor (vWF) and platelets. The interaction of platelets with type VI collagen and the roles of platelet glycoprotein (GP) receptors and vWF were studied under flow conditions using epi-fluorescent videomicroscopy coupled with digital image processing. We found that surface coverage was less than 6% on collagen VI at a relatively high-wall shear rate (1,000 s-1) and was approximately 60% at a low-wall shear rate (100 s-1). The molecular mechanisms involved in low-shear platelet binding were studied using monoclonal antibodies to platelet GPIb and GPIIb-IIIa, and polymeric aurin tricarboxylic acid. Anti-GPIIb-IIIa was the most effective in eliminating adhesion (surface coverage, 0.8%), followed by anti-GPIb (4.3%), and ATA (12.6%). Experiments with von Willebrand disease blood indicate that vWF is involved in platelet adhesion to collagen VI at 100 s-1. In the absence of vWF, there may be direct binding of platelet GPIIb-IIIa complexes to collagen VI. Adhesion and aggregation on collagen VI are different in shear rate dependence from collagen I. Our results suggest a possible role for collagen VI and vWF in platelet adhesion and aggregation in vascular regions with low shear rates.
VI型胶原蛋白是一种内皮下成分,可结合血管性血友病因子(vWF)和血小板。利用落射荧光显微镜结合数字图像处理技术,在流动条件下研究了血小板与VI型胶原蛋白的相互作用以及血小板糖蛋白(GP)受体和vWF的作用。我们发现,在相对较高的壁面剪切速率(1000 s-1)下,VI型胶原蛋白表面的覆盖率小于6%,而在低壁面剪切速率(100 s-1)下约为60%。使用针对血小板糖蛋白Ib和糖蛋白IIb-IIIa的单克隆抗体以及聚合金精三羧酸,研究了低剪切力下血小板结合所涉及的分子机制。抗糖蛋白IIb-IIIa在消除黏附方面最有效(表面覆盖率为0.8%),其次是抗糖蛋白Ib(4.3%)和金精三羧酸(12.6%)。对血管性血友病血液进行的实验表明,vWF在100 s-1时参与血小板与VI型胶原蛋白的黏附。在没有vWF的情况下,血小板糖蛋白IIb-IIIa复合物可能会直接与VI型胶原蛋白结合。VI型胶原蛋白上的黏附和聚集在剪切速率依赖性方面与I型胶原蛋白不同。我们的结果表明,VI型胶原蛋白和vWF在低剪切速率的血管区域的血小板黏附和聚集中可能发挥作用。